Advancing cooperation on health technology assessment (HTA) and supporting the implementation of the new EU legal framework on HTA
D5.3 on selection criteria for assessor and co-assessor of Joint Clinical Assessments is open for public consultation between March 7 and April 5, 2022, 23:59 CET.
The public consultation for EUnetHTA 21 Deliverable 5.3 on selection criteria for assessor and co-assessor of Joint Clinical Assessments (JCA) is open for public consultation
Publication of Project Plans
We are pleased to announce the Project Plans for the deliverables in the EUnetHTA 21 Service Contract (2021-2023) are published. They provide a general overview and describe the objectives, approach and timelines
[Closed] EUnetHTA 21 launches Open Call for JSC
EUnetHTA 21 is launching the first Open Call for applications from the pharmaceutical industry for four Joint Scientific Consultations (JSC), starting in January 2022. These
EUnetHTA 21 – first Stakeholder Kick-Off Meeting
EUnetHTA 21 Secretariat is pleased to announced that the first EUnetHTA 21 Stakeholder Kick-Off Meeting is scheduled, online, for 03.12.2021 at 10:30-12:00 CET. The meeting will entail a high-level focus
EUnetHTA 21 JSC – open calls
As one of the first milestones of EUnetHTA 21, we will soon launch the first open call to pharmaceutical industry for applications for the upcoming
European HTA agencies launch the Heads of Agencies Group (HAG)
On 29 September 2021, the heads of 19 European HTA agencies came together and inaugurated a new HTA-focused collaborative network for high-level strategic exchange and
Joint HTA Work
EUnetHTA develops several services that help inform the decision-making process around the introduction of pharmaceuticals and other technologies at the national, regional, and European levels. These include Joint Scientific Consultations, Parallel Consultations, and Post Launch Evidence Generation (PLEG). Find out more here.
Tools
EUnetHTA has developed a suite of tools to complement all steps in the collaborative joint work process, helping partners to proceed with a defined methodology. Access all current and archived tools here.
COVID-19 Response
EUnetHTA has prioritised COVID-19-related initiatives above other work during the current time. Here you will find updated information and publications relating to COVID-19 diagnostic testing, therapeutic treatments, and useful links to further data from our network partners.
Get Involved
EUnetHTA functions as a collaboration between network members and exterior partners to develop joint work. These include patients, industry, regulators, HCPs, and payers. Find out more about partner involvement, activities, and EUnetHTA events here.